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Editorial

Plasma Processes and Polymers Special Issue
on: Plasma and Cancer
Guest Editors:
Mounir Laroussi, Old Dominion
University
Michael Keidar, George Washington
University
During the last two decades, research efforts on the application of
low temperature plasmas in biology
and medicine have positioned nonequilibrium low temperature plasmas
as a technology that has the potential
of revolutionizing healthcare.[1,2] Low
temperature plasmas can be applied
in direct contact with living tissues to
inactivate bacteria,[3] to disinfect
wounds and accelerate wound healing,[4] and to induce damage in some
cancer cells.[5–11] The research work on
all the above mentioned applications
constitutes a new scientific field today
known as ‘‘Plasma Medicine.’’ This
fascinating multidisciplinary field,
which involves physics, chemistry,
engineering, and biology is rather
young and has been around for only
two decades. It is not to be confused
with the old (and rather controversial)
fields of electrotherapy or carbon arc
lamps therapies where plasma (even
if present) does not play a direct or
central biological role in the therapy.
Plasma medicine as we know it today
had its beginnings about two decades
ago under a US Air Force Office of
Scientific Research (AFOSR) funded
program that sought to use nonequilibrium atmospheric pressure
plasmas (including air plasma) to
inactivate pathogens in order to decontaminate/sterilize both abiotic
and biotic materials. This program
aimed at developing and optimizing a
plasma-based technology that can be
used in forward deployed military
theaters to decontaminate gear (abiotic) and to disinfect soldiers’ wounds
(biotic) and speed up the wound
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healing process. Subsequently, and
by the turn of the century, plasma
medicine as a field of research developed quite rapidly and today involves
the study of both fundamental scientific investigations as well as the
applied aspects of the interaction of
low temperature, atmospheric pressure plasma with biological cells and
biological systems. By low temperature plasma it is meant plasma with
biologically tolerable gas temperatures. This usually means temperatures less than 40 8C (or about
313 K). In plasma medicine, the plasma is not treated as a ‘‘black box’’ that
has magical effects on biological
systems. To the contrary, the plasma
itself is carefully investigated and
characterized in details using advanced diagnostics methods. This is
done so that each plasma-generated
agent that may have biological implication is identified and quantitatively
measured. This is one of the key roles
played by the plasma physicists working in the field. The role of the
biologists/biochemists is to determine the effect of each of these agents,
alone or in synergy with others, on the
cellular and sub-cellular levels. This
includes physical effects, chemical
effects, and cell signaling. With this
collaboration between physicists,
engineers, and biologists/biochemists
the scientific inquiry into the interaction of plasma with biological cells has
quickly progressed from its humble
beginning of the mid 1990’s to more
complex lines of research involving
both healthy and cancerous mammalian cells, with major research milestones and advances occurring almost
every two years. As more medicaloriented plasma applications/therapies are proposed, the collaboration
has also recently expanded to include
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medical researchers and personnel.
This is justifying more and more the
inclusion of the word ‘‘medicine’’ in
the name of this new field of application of plasma.
Low temperature plasmas are
known to exhibit enhanced gas phase
chemistry without the need for elevated temperatures. It is this remarkable characteristic that allows the use
of these plasmas in biological and
medical applications. It has been
found that the plasma-generated reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a
major role in the interaction of low
temperature plasmas with biological
cells.[1,2] These chemical species which
include O, O2 , OH NO, and NO2 exhibit
strong oxidative properties and/or
trigger signaling pathways in biological cells. The fact that these biochemical mechanisms and pathways can be
activated with plasmas that are generated at atmospheric pressure and
that remain at temperatures close to
room temperature makes plasma an
attractive medium upon which new
medical therapies can be established.
One of the relatively recent findings
is the realization that low doses of
plasma can induce apoptosis, or programmed cell death. This opened up
the possibility to use plasma technology to kill cancerous cells in vitro and
in vivo.[5–11] Of all the possible applications of low temperature plasma in
biology and medicine, the killing of
cancer cells could lead to a paradigm
shift in the way cancer tumors and
lesions can be treated without serious
side effects to the patient. However,
this exciting prospect can only be
achieved after extensive fundamental
scientific work is done to understand
the complex interaction of plasma
with cells in general and with cancer
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cells in particular. This highly interdisciplinary work requires a close
collaboration between plasma physicists/engineers and biology/microbiology/biochemistry experts. Research
efforts, being now conducted in various labs around the world, are aiming
at elucidating the intricate physical
and biochemical processes that play a
role when cancer cells are exposed to
plasma.
With the already achieved advances
in the understanding of how plasma
interacts with cancer cells, the guest
editors and the editorial board of
Plasma Processes and Polymers (PPaP)
felt that time has arrived to publish
quality papers from the leading
experts in a consolidated special issue.
This initiative resulted in an excellent
collection of papers that greatly
enriches the literature related to plasma medicine in general and the
application of low temperature plasma to cancer in particular. The topics
covered by the papers included in this
special issue range from molecular
dynamics simulations of the interaction between plasma and biomolecules and tissues, to the chemistry
involved when plasma is applied to
biological systems, and to the destruction of various cancer cells by plasma.
The prospects of plasma technology

as a new possible player in cancer
therapy of the 21st century are also
discussed. Many of the topics discussed in this issue were presented
at the inaugural First Workshop on
Plasma for cancer Treatment (IWPCT-1)
which took place at the George
Washington University Convention
Center in Washington DC, USA,
March 25–26, 2014. At this meeting,
which was organized by the guest
editors of this special issue, world
experts from eleven countries (4 continents) gathered to discuss the stateof-the-art of plasma application in
cancer.
The guest editors would like to
thank the editorial board of PPaP for
supporting the idea of publishing a
special issue on ‘‘plasma and cancer.’’
We are very grateful to Renate Forch
for expertly coordinating the special
issue with great care and enthusiasm.
In addition, a big thank you goes to the
reviewers who invested time and
effort in ensuring that the contents
of the papers are free of mistakes and
are of the best quality possible. Last
but not least we would like to thank
the authors for their excellent contributions to this special issue which is
truly special as it is the first such
journal issue, mainly dedicated to
the topic of the effects of low temper-
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ature plasmas on cancer cells and to
the prospects of plasma technology as
a possible future cancer treatment
modality.
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